GELESIS HOLDINGS, INC.

Capstar Special Purpose Acquisition Corp., trading under the ticker CPSR, completed a SPAC merger with Gelesis Holdings, Inc., a biotech company focused on weight management and metabolic health. The deal was announced in July 2021 and closed in early 2022, with the combined company listing on the New York Stock Exchange under the ticker GLS. Capstar Special Purpose Acquisition Corp. raised capital through its 2021 IPO and targeted the biotech and pharmaceutical sector. Gelesis is best known for developing Plenity, an FDA-cleared superabsorbent hydrogel treatment for weight management. The transaction's status is closed. Sign up for a SpacDesk account to access full deal data, filing timelines, and sponsor profiles on this and hundreds of other SPAC transactions.

SPAC Counterparty (1)